SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in

Erika Gurzeler1, Anna-Kaisa Ruotsalainen1, Anssi Laine1

  • 1A.I. Virtanen Institute, University of Eastern Finland, Kuopio, Finland.

Plos One
|November 12, 2021
PubMed

Insights

The SUR1-E1506K mutation worsens atherosclerosis in mice by impairing glucose tolerance and increasing arterial inflammation, leading to more vulnerable plaques. This highlights a link between diabetes risk factors and cardiovascular disease progression.

Area of Science:

  • Cardiovascular Biology
  • Metabolic Disease Research
  • Genetic Mutation Impact Studies

Background:

  • Diabetes mellitus is a significant risk factor for atherosclerosis.
  • The sulfonylurea receptor 1 (SUR1) E1506K mutation causes hyperinsulinemia and increases type 2 diabetes risk.
  • Investigating the SUR1-E1506K mutation's role in atherosclerosis is crucial for understanding diabetes complications.

Purpose of the Study:

  • To determine the effect of the SUR1-E1506K mutation on atherogenesis.
  • To analyze plaque morphology and vulnerability in a mouse model.
  • To assess glucose metabolism and arterial inflammation associated with the mutation.

Main Methods:

  • Cross-breeding SUR1-E1506K mutated mice with LDLR-/- mice.
  • Feeding a Western diet to induce atherosclerosis in 6-month-old mice for 6 months.
  • Analyzing atherosclerotic plaque characteristics, glucose metabolism, and inflammatory markers (IL-1β, NLRP3, IL-18).

Main Results:

  • SUR1Δ/LDLR-/- mice showed increased plaque necrotic area and reduced smooth muscle cells, indicating higher vulnerability.
  • Impaired glucose tolerance and elevated fasting glucose were observed in SUR1Δ/LDLR-/- mice post-diet.
  • Increased IL-1β, NLRP3 inflammasome, and IL-18 levels were found in aortic sections and macrophages of SUR1Δ/LDLR-/- mice.

Conclusions:

  • The SUR1-E1506K mutation exacerbates atherosclerosis by promoting a vulnerable plaque phenotype.
  • Impaired glucose tolerance and heightened arterial inflammation are key consequences of the mutation.
  • This study links specific genetic mutations related to diabetes to adverse cardiovascular outcomes.
Abstract